Atosiban
SIGMA/A3480 - ≥98% (HPLC)
Synonym: 1-
CAS Number: 90779-69-4
Empirical Formula (Hill Notation): C43H67N11O12S2
Molecular Weight: 994.19
MDL Number: MFCD00672436
Linear Formula: C43H67N11O12S2
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white |
| form | lyophilized powder |
| InChI | 1S/C43H67N11O12S2/c1-5-23 |
| InChI key | VWXRQYYUEIYXCZ-OBIMUBPZSA |
| originator | Ferring |
| Quality Level | 100 ![]() |
| shipped in | wet ice |
| SMILES string | [H][C@]1(NC(=O)[C@@]([H]) |
| solubility | H2O: ≤100 mg/mL |
| storage condition | desiccated |
| storage temp. | −20°C |
| Application: | Atosiban has been used: • as an oxytocin receptor antagonist • in the calcium mobilization assay for Z factor determination in uterine myometrium (UT-myo cells) and as a therapeutic agent to inhibit preterm labor • to inhibit the activation of oxytocin-receptor-express |
| Biochem/physiol Actions: | Atosiban efficiently prevent preterm uterine contractions without any major cardiovascular, pulmonary or central nervous system side effects. It has potential to treat preterm labour. |
| Biochem/physiol Actions: | Atosiban is a peptide oxytocin receptor antagonist. |
| Features and Benefits: | This compound was developed by Ferring . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 10 mg in glass bottle |
| Preparation Note: | Reconstitute in deionized water at not less than 100 μg/mL, which can then be diluted into aqueous vehicle of choice. Solutions may be stored at 2-8 °C for up to seven days. For extended storage, add a carrier protein of 0.1% human serum albumin or bovine serum albumin and freeze in working aliquots at −20 °C. |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 51111800 |

